Variant report

Variant	nsv914967
Chromosome Location	chr22:30103476-30133579
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:638)
CpG islands
(count:1344)
Chromatin interactive
region (count:23)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:638 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr22:30112673-30113047	HepG2	liver:	n/a	n/a
2	ATF3	chr22:30123277-30123446	K562	blood:	n/a	n/a
3	BACH1	chr22:30117117-30117164	H1-hESC	embryonic stem cell:	n/a	n/a
4	BHLHE40	chr22:30128256-30128610	K562	blood:	n/a	n/a
5	BHLHE40	chr22:30112938-30112959	K562	blood:	n/a	n/a
6	BHLHE40	chr22:30123039-30123491	K562	blood:	n/a	chr22:30123301-30123317 chr22:30123298-30123314
7	BHLHE40	chr22:30129772-30130101	K562	blood:	n/a	n/a
8	BHLHE40	chr22:30129783-30130011	GM12878	blood:	n/a	n/a
9	BHLHE40	chr22:30122204-30122269	K562	blood:	n/a	n/a
10	BRCA1	chr22:30129764-30130130	Hela-S3	cervix:	n/a	n/a
11	CBX3	chr22:30122729-30123043	K562	blood:	n/a	n/a
12	CBX3	chr22:30128277-30128548	K562	blood:	n/a	n/a
13	CCNT2	chr22:30130069-30130217	K562	blood:	n/a	n/a
14	CCNT2	chr22:30122115-30122354	K562	blood:	n/a	n/a
15	CEBPB	chr22:30106956-30107195	Hela-S3	cervix:	n/a	n/a
16	CEBPB	chr22:30123247-30123550	HepG2	liver:	n/a	n/a
17	CEBPB	chr22:30112795-30113094	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr22:30129150-30130110	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr22:30123253-30123563	K562	blood:	n/a	n/a
20	CEBPB	chr22:30112775-30113097	HepG2	liver:	n/a	n/a
21	CEBPB	chr22:30129294-30130046	ECC-1	luminal epithelium:	n/a	n/a
22	CEBPB	chr22:30112810-30112951	HepG2	liver:	n/a	n/a
23	CEBPB	chr22:30129409-30129687	K562	blood:	n/a	n/a
24	CEBPB	chr22:30120297-30120612	HepG2	liver:	n/a	chr22:30120448-30120459
25	CEBPB	chr22:30123286-30123530	A549	lung:	n/a	n/a
26	CEBPB	chr22:30120413-30120592	Hela-S3	cervix:	n/a	chr22:30120448-30120459
27	CEBPB	chr22:30123242-30123551	H1-hESC	embryonic stem cell:	n/a	n/a
28	CEBPB	chr22:30129330-30129738	ECC-1	luminal epithelium:	n/a	n/a
29	CEBPB	chr22:30123189-30123587	MCF-7	breast:	n/a	n/a
30	CEBPB	chr22:30120445-30120468	IMR90	lung:	n/a	chr22:30120448-30120459
31	CEBPB	chr22:30123245-30123541	IMR90	lung:	n/a	n/a
32	CEBPB	chr22:30112805-30112998	K562	blood:	n/a	n/a
33	CEBPB	chr22:30129437-30129695	K562	blood:	n/a	n/a
34	CEBPB	chr22:30112804-30113093	IMR90	lung:	n/a	n/a
35	CEBPB	chr22:30123279-30123521	Hela-S3	cervix:	n/a	n/a
36	CEBPB	chr22:30120302-30120606	MCF-7	breast:	n/a	chr22:30120448-30120459
37	CEBPB	chr22:30120332-30120505	A549	lung:	n/a	chr22:30120448-30120459
38	CEBPD	chr22:30129823-30130320	K562	blood:	n/a	n/a
39	CEBPD	chr22:30123286-30123454	HepG2	liver:	n/a	n/a
40	CHD2	chr22:30122854-30123003	K562	blood:	n/a	n/a
41	CHD2	chr22:30106924-30107562	Hela-S3	cervix:	n/a	n/a
42	CHD2	chr22:30129375-30130073	Hela-S3	cervix:	n/a	n/a
43	CHD2	chr22:30112908-30113057	HepG2	liver:	n/a	n/a
44	CTCF	chr22:30108863-30108879	MCF-7	breast:	n/a	n/a
45	CTCF	chr22:30123235-30123470	NHEK	skin:	n/a	n/a
46	CTCF	chr22:30123280-30123430	HFF	foreskin:	n/a	n/a
47	CTCF	chr22:30119840-30119990	HPAF	blood vessel:	n/a	n/a
48	CTCF	chr22:30131440-30131590	GM06990	blood:	n/a	n/a
49	CTCF	chr22:30123296-30123435	Kidney_OC	kidney:	n/a	n/a
50	CTCF	chr22:30119880-30120030	GM12864	blood:	n/a	n/a

(count:1344 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr22:30127118-30127168	ovcar-3	ovarian:	n/a
2	chr22:30116919-30116969	GM12878	blood:	n/a
3	chr22:30127118-30127168	ovcar-3	ovarian:	n/a
4	chr22:30116919-30116969	GM12878	blood:	n/a
5	chr22:30122327-30122377	HMEC	breast:	n/a
6	chr22:30125353-30125403	T-47D	breast:	n/a
7	chr22:30127118-30127168	GM19239	blood:	n/a
8	chr22:30115154-30115204	GM12878	blood:	n/a
9	chr22:30115348-30115398	ProgFib	skin:	n/a
10	chr22:30116319-30116369	ProgFib	skin:	n/a
11	chr22:30115348-30115398	A549	lung:	n/a
12	chr22:30115203-30115253	HL-60	blood:	n/a
13	chr22:30116328-30116378	ProgFib	skin:	n/a
14	chr22:30116953-30117003	AG09309	skin:	n/a
15	chr22:30116037-30116087	SK-N-MC	brain:	n/a
16	chr22:30115154-30115204	PrEC	prostate:	n/a
17	chr22:30119712-30119762	AG04449	skin:	fetal
18	chr22:30119712-30119762	GM19239	blood:	n/a
19	chr22:30125353-30125403	NHDF-neo	bronchial:	n/a
20	chr22:30107178-30107228	GM06990	blood:	n/a
21	chr22:30117148-30117198	Caco-2	colon:	n/a
22	chr22:30112403-30112453	NT2-D1	testis:	n/a
23	chr22:30116328-30116378	AG04450	lung:	fetal
24	chr22:30112403-30112453	A549	lung:	n/a
25	chr22:30116439-30116489	SK-N-SH	brain:	n/a
26	chr22:30127118-30127168	SK-N-SH	brain:	n/a
27	chr22:30125353-30125403	LNCaP	prostate:	n/a
28	chr22:30129607-30129657	AoSMC	blood vessel:	n/a
29	chr22:30125642-30125692	H1-hESC	embryonic stem cell:	embryo
30	chr22:30119712-30119762	HCF	heart:	n/a
31	chr22:30115154-30115204	U87	brain:	n/a
32	chr22:30117159-30117209	HL-60	blood:	n/a
33	chr22:30116319-30116369	RPTEC	kidney:	n/a
34	chr22:30129607-30129657	HCT-116	colon:	n/a
35	chr22:30112403-30112453	LNCaP	prostate:	n/a
36	chr22:30127118-30127168	HRPEpiC	eye:	n/a
37	chr22:30112403-30112453	SK-N-SH_RA	brain:	n/a
38	chr22:30125353-30125403	HRE	kidney:	n/a
39	chr22:30117148-30117198	HPAEpiC	pulmonary alveolar:	n/a
40	chr22:30116319-30116369	AG10803	skin:	n/a
41	chr22:30125642-30125692	IMR90	lung:	fetal
42	chr22:30115348-30115398	Hela-S3	cervix:	n/a
43	chr22:30115154-30115204	K562	blood:	n/a
44	chr22:30112403-30112453	AG10803	skin:	n/a
45	chr22:30116439-30116489	PANC-1	pancreas:	n/a
46	chr22:30107178-30107228	NB4	blood:	n/a
47	chr22:30107178-30107228	AG09319	gingival:	n/a
48	chr22:30125642-30125692	HepG2	liver:	n/a
49	chr22:30116037-30116087	PANC-1	pancreas:	n/a
50	chr22:30125642-30125692	LNCaP	prostate:	n/a

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr22:30114234..30116768-chr22:30120016..30122557,3	MCF-7	breast:
2	chr22:30126344..30127866-chr22:30201046..30202629,2	K562	blood:
3	chr22:30103672..30106590-chr22:30107402..30109092,2	MCF-7	breast:
4	chr22:30117740..30119771-chr22:30165612..30167453,2	MCF-7	breast:
5	chr22:30126165..30128637-chr22:30161660..30163491,2	MCF-7	breast:
6	chr22:30124714..30127862-chr22:30128538..30131492,3	K562	blood:
7	chr22:30122754..30125379-chr22:30128810..30131334,3	MCF-7	breast:
8	chr22:30118032..30120779-chr22:30154984..30156711,2	K562	blood:
9	chr22:30122754..30125379-chr22:30128810..30131334,3	MCF-7	breast:
10	chr22:30101634..30103485-chr22:30110793..30113259,2	K562	blood:
11	chr22:30119899..30121884-chr22:30123778..30126684,2	MCF-7	breast:
12	chr22:30128408..30130433-chr22:30161291..30163799,2	MCF-7	breast:
13	chr22:30096968..30098760-chr22:30102459..30104662,3	MCF-7	breast:
14	chr22:30119899..30121884-chr22:30123778..30126684,2	MCF-7	breast:
15	chr22:30096975..30100180-chr22:30101896..30105574,4	K562	blood:
16	chr22:30127476..30130014-chr22:30183535..30186061,2	MCF-7	breast:
17	chr22:30101634..30103485-chr22:30110793..30113259,2	K562	blood:
18	chr22:30130941..30133818-chr22:30144985..30147499,2	MCF-7	breast:
19	chr22:30123279..30125899-chr22:30126231..30128918,2	K562	blood:
20	chr22:30123279..30125899-chr22:30126231..30128918,2	K562	blood:
21	chr22:30103672..30106590-chr22:30107402..30109092,2	MCF-7	breast:
22	chr22:30120187..30123071-chr22:30140004..30142315,2	K562	blood:
23	chr22:30124714..30127862-chr22:30128538..30131492,3	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZMAT5-1	chr22:30115537-30115737	XLOC_014338
2	lnc-ZMAT5-1	chr22:30115537-30115848	XLOC_014338
3	lnc-ZMAT5-1	chr22:30114214-30114787	NONHSAT084729
4	lnc-ZMAT5-1	chr22:30115537-30115756	NONHSAT084729
5	lnc-ZMAT5-1	chr22:30107809-30107906	XLOC_014338
6	lnc-ZMAT5-1	chr22:30107802-30107984	XLOC_014338
7	lnc-ZMAT5-1	chr22:30115558-30115703	XLOC_014338

No data

Variant related genes	Relation type
ENSG00000232396	TF binding region
ENSG00000239446	TF binding region
CABP7	TF binding region
ENSG00000232396	CpG island
ENSG00000239446	CpG island
CABP7	CpG island
ENSG00000100314	chromatin interactions
ENSG00000239446	chromatin interactions
ENSG00000100319	chromatin interactions
ENSG00000232396	chromatin interactions
ENSG00000184076	chromatin interactions
NID1	miRNA target sites
NHLRC3	miRNA target sites

Extended variants
information (count: 1224 )
Associated
traits (count: 70 )

Variant overlapped rSNPs/rCNVs (count:1224 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2530682	chr22:30103476-30103477	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs182845487	chr22:30103519-30103520	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs574323141	chr22:30103547-30103548	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs544470191	chr22:30103600-30103601	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs563107939	chr22:30103685-30103686	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs35921780	chr22:30103701-30103702	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs577669444	chr22:30103704-30103705	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs548685974	chr22:30103706-30103707	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs73390954	chr22:30103747-30103748	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs531148032	chr22:30103797-30103798	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs2527342	chr22:30103819-30103820	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs186042453	chr22:30103832-30103833	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs571210249	chr22:30103837-30103838	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs561021072	chr22:30103858-30103859	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs531670431	chr22:30103924-30103925	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs147000515	chr22:30103980-30103981	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs34906197	chr22:30103997-30103998	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs571467160	chr22:30104005-30104006	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs138132370	chr22:30104019-30104020	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs375032491	chr22:30104037-30104038	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs547502308	chr22:30104052-30104053	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs369397719	chr22:30104077-30104078	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs565811626	chr22:30104148-30104149	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs535870155	chr22:30104159-30104160	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs554591434	chr22:30104264-30104265	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs558611861	chr22:30104274-30104275	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs564922985	chr22:30104284-30104285	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs131257	chr22:30104285-30104286	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs113710584	chr22:30104288-30104289	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs116844839	chr22:30104351-30104352	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs556310019	chr22:30104393-30104394	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs577830307	chr22:30104395-30104396	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs545230286	chr22:30104429-30104430	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs560191239	chr22:30104501-30104502	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs572251315	chr22:30104527-30104528	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs143096331	chr22:30104563-30104564	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs554656603	chr22:30104638-30104639	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs148220165	chr22:30104640-30104641	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs560656803	chr22:30104650-30104651	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs141180285	chr22:30104706-30104707	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs565215950	chr22:30104710-30104711	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs546408815	chr22:30104739-30104740	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs532325690	chr22:30104795-30104796	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs191231460	chr22:30104815-30104816	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs150721800	chr22:30104816-30104817	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs536357687	chr22:30104827-30104828	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs527709515	chr22:30104842-30104843	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs376890157	chr22:30104856-30104857	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs35360305	chr22:30104857-30104858	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs2530683	chr22:30104909-30104910	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:70)

Disease	PMID	Source
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Velocardiofacial syndrome	20111667	CNVD
Medulloblastoma	21979893	CNVD
sporadic solitary meningiomas	19589153	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Congenital heart defect	22511896	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Acute myeloid leukemia	16864856	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	17387387	CNVD
Seminomas	18059402	CNVD
Cancer	16751803	CNVD
Metanephric adenoma	20802469	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Metachromatic leukodystrophy	18421352	CNVD
Basal cell lymphoma	17170743	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Breast cancer	21858162	CNVD
Myelodysplastic syndrome	21251322	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Melanoma	18172304	CNVD
Ovarian cancer	22174824	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Wilms tumour	21544195	CNVD
Acute myeloid leukemia	21251322	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Lung cancer	18438408	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
small cell lung cancer	20016488	CNVD
Cancer	21183584	CNVD
Renal cell carcinoma	18765545	CNVD
Schizophrenia	19521646	CNVD
Schizophrenia	18990708	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Hepatocellular carcinoma	16750200	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Non-small cell lung cancer	21829676	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Autism	17322880	CNVD
Breast cancer	20409316	CNVD
Neurofibromatosis type 2	19566914	CNVD
Autism	19384346	CNVD
Melanoma	17363583	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:859 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr22:30096000-30103600	Enhancers	Fetal Brain Male	brain
2	chr22:30096400-30103600	Enhancers	Brain Inferior Temporal Lobe	brain
3	chr22:30096400-30107400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
4	chr22:30096600-30103800	Enhancers	Brain Cingulate Gyrus	brain
5	chr22:30097000-30106400	Weak transcription	Psoas Muscle	Psoas
6	chr22:30098800-30115600	Weak transcription	Right Atrium	heart
7	chr22:30099400-30103600	Enhancers	Brain Germinal Matrix	brain
8	chr22:30100800-30103600	Enhancers	Brain Substantia Nigra	brain
9	chr22:30101000-30103600	Enhancers	Brain Angular Gyrus	brain
10	chr22:30101400-30104800	Weak transcription	HSMMtube	muscle
11	chr22:30101600-30103800	Enhancers	Brain Hippocampus Middle	brain
12	chr22:30102400-30103600	Bivalent Enhancer	Fetal Muscle Leg	muscle
13	chr22:30102800-30103600	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr22:30102800-30103600	Bivalent Enhancer	Fetal Stomach	stomach
15	chr22:30102800-30104200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr22:30102800-30105200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr22:30102800-30106000	Weak transcription	Spleen	Spleen
18	chr22:30103200-30106400	Weak transcription	Fetal Brain Female	brain
19	chr22:30103600-30106200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr22:30103600-30106400	Weak transcription	Fetal Brain Male	brain
21	chr22:30104600-30105200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
22	chr22:30104600-30108000	Enhancers	Fetal Muscle Leg	muscle
23	chr22:30104800-30105200	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
24	chr22:30104800-30105200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
25	chr22:30104800-30105800	Enhancers	HSMMtube	muscle
26	chr22:30105000-30105200	Bivalent Enhancer	Right Ventricle	heart
27	chr22:30105800-30106200	Weak transcription	HSMMtube	muscle
28	chr22:30105800-30108400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr22:30106000-30106200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
30	chr22:30106000-30106200	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
31	chr22:30106000-30106600	Enhancers	Hela-S3	cervix
32	chr22:30106000-30107000	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
33	chr22:30106000-30107400	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
34	chr22:30106000-30107800	Enhancers	Spleen	Spleen
35	chr22:30106200-30106800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
36	chr22:30106200-30107600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr22:30106200-30107800	Enhancers	HSMMtube	muscle
38	chr22:30106400-30107200	Enhancers	Psoas Muscle	Psoas
39	chr22:30106400-30107400	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
40	chr22:30106400-30107600	Enhancers	Fetal Brain Male	brain
41	chr22:30106400-30107800	Enhancers	Fetal Brain Female	brain
42	chr22:30106400-30107800	Enhancers	Pancreas	Pancrea
43	chr22:30106600-30106800	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
44	chr22:30106600-30106800	Bivalent Enhancer	Fetal Intestine Large	intestine
45	chr22:30106600-30107000	Bivalent Enhancer	Brain Hippocampus Middle	brain
46	chr22:30106600-30107400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
47	chr22:30106600-30107400	Bivalent Enhancer	Stomach Smooth Muscle	stomach
48	chr22:30106600-30107400	Flanking Active TSS	Hela-S3	cervix
49	chr22:30106800-30107000	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
50	chr22:30106800-30107000	Enhancers	Skeletal Muscle Female	skeletal muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links